PDCD1 and neoplasm: These tumors are known to be highly infiltrated with myeloid cells which may act as external suppressors of anti-tumor immune responses that are not relieved by PD-1 checkpoint blockade [31], raising the possibility of future gene signatures that may by combined with TIS to further dissect immune responses.